-93%

est. 2Y upside i

HealthcareSeed

Dermatology telehealth app for LatAm

Rank

#2255

Sector

Healthtech

Est. Liquidity

~5Y

Data Quality

Data: Low

This equity opportunity presents moderate upside potential driven by a growing market and a diversified revenue model, but job seekers must weigh this against the higher risk associated with a thin competitive moat, intense local competition, and limited funding for an early-stage company in a regulated sector.

Last updated: February 16, 2026

Bull (15%)+350%

My NextDerma achieves significant market penetration in Mexico, successfully expands its product lines, and secures a substantial Series A or B funding round at a much higher valuation within two years.

Base (40%)+75%

The company experiences continued modest growth, maintains its market position despite competition, and potentially raises a follow-on seed or small Series A round, leading to a moderate increase in equity value.

Bear (45%)-90%

My NextDerma struggles to scale due to intense competition, fails to raise subsequent funding, or faces insurmountable regulatory hurdles, resulting in a significant loss of equity value or company failure.

Est. time to liquidity~5.0 years

Community

Valuation Sentiment

Our model estimates -93% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.